Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-047125
Filing Date
2010-09-17
Accepted
2010-09-17 14:50:45
Documents
1
Period of Report
2010-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd286534.html 4  
1 FORM 4 rrd286534.xml 4 3875
  Complete submission text file 0001181431-10-047125.txt   5642
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ASYA ALEXANDROVICH ONE FINANCIAL CENTER BOSTON MA 021111
Business Address
MURPHY JAMES B (Reporting) CIK: 0001282721 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 101078033